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Background: Canine leishmaniosis (CanL) is an endemic zoonosis in the southern regions of Europe. This paper
reports the trend in CanL seroprevalence in the municipality of Évora (southern Portugal), where the disease is
endemic, over a period of 20 years. The work comprises three different studies that were conducted in the years of
1990 (n = 3,614), 1999 (n = 3,563) and 2010 (n = 1,485 dogs). Blood samples were collected during the anti-rabies
vaccination campaigns. Anti-Leishmania antibodies were detected with the direct agglutination test (DAT).
Findings: The total percentages of DAT seropositive dogs were 3.9% (in 1990), 9.4% (in 1999) and 5.6% (in 2010).
The overall seroprevalence was significantly higher in 1999 compared to 1990, but in 2010 a significant decrease
was found in comparison with 1999. However, compared to 1990 the overall seroprevalence was still significantly
higher in 2010. From 1990 to 2010 seroprevalence has switched from significantly lower to higher in the rural areas.
Relatively few dogs showed clinical signs of overt disease (0.8% to 2.0%) with lymphadenopathy, onychogryphosis
and skin involvement as most frequently observed. Gender associated differences in seroprevalence were not
found, and most commonly seropositive dogs were working or stray animals. The mean age of seropositive dogs
was significantly higher than seronegative dogs in all three sampling rounds.
Conclusions: A high proportion of dogs, which are apparently healthy, yet seropositive, may remain an important
factor in limiting the outcome of zoonotic leishmaniosis control efforts.
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Leishmaniosis, a disease caused by protozoan parasites
of the genus Leishmania, is one of the major commu-
nicable diseases in the world and one of the most-
important vector-borne parasitic diseases after malaria
[1]. Dogs are the main domestic reservoir for human
infection where zoonotic leishmaniosis is caused by
Leishmania infantum [2]. Canine leishmaniosis (CanL)
is a systemic chronic disease and clinical manifestations
usually include lymphadenopathy, dermatitis, alopecia,
cutaneous ulcerations, onychogryphosis, lameness, an-
orexia, weight loss, cachexia, ocular lesions, epistaxis,
anaemia, diarrhoea, and renal failure [3]. Even when they
receive treatment, severely affected dogs do not often* Correspondence: lcardoso@utad.pt
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reproduction in any medium, provided the orsurvive the disease. Nevertheless, a significant propor-
tion of infected animals remain asymptomatic [4], but
these asymptomatic infected dogs may act as carriers of
L. infantum and are capable of transmitting the parasite
to the vector, the phlebotomine sand flies [5]. CanL is
endemic in all countries of the Mediterranean basin, in-
cluding the European countries Portugal, Spain, France,
Italy, Greece, Croatia, Albania, Malta, and Cyprus.
Emerging trends in the seroprevalence of CanL in many
traditional leishmaniosis foci are being reported [4,6-8].
Possibly due to global warming, CanL is currently also
being reported in foci outside the classical area of the
disease in the Mediterranean countries [9-11]. For ex-
ample, cases of autochthonous CanL have recently been
reported from Hungary [12] and Germany [13].
In Portugal, there are four main CanL foci: the prov-
ince of Trás-os-Montes e Alto Douro (in the north), the
region of Lisbon (in the west), the province of Algarve
(in the south) and the municipality of Évora (in the
southern region of Alentejo). Previous studies conductedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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there is a considerable prevalence of CanL in northern
Portugal with approximately 20% of dogs being sero-
positive [14,15]. In the context of emerging disease,
the present study describes trends in seroprevalence
of CanL over two decades in the municipality of
Évora in southern Portugal (38° 34′ 17″ N, 07° 54′
31″ W). Évora comprises 19 different administrative
sections (parishes) of which eight are considered to be
urban and the other rural, covering an area of
1,307.04 km2 with an average altitude of 300 m above
sea level. The climate and vegetation are typically
Mediterranean, with dry hot summers (32-35°C) and
maximum rainfall in spring and autumn, and mild
winters with temperatures rarely going below 5°C.
The sand fly season runs from May to October:
Phlebotomus sergenti is the most abundant species,
followed by Phlebotomus perniciosus [16]. The known
species of Leishmania is L. infantum MON-1 [17].
This study was approved by the University of Évora
ethics committee for research in health sciences and
well-being as complying with the Portuguese legisla-
tion for the protection of animals (Law no. 92/1995,
from September the 12th). Dogs were surveyed during
the yearly anti-rabies vaccination campaigns in 1990
(n = 3,614), 1999 (n = 3,563) and 2010 (n = 1,485).
All animals were clinically examined by veterinary
practitioners and considered as either apparently
healthy or clinically suspect, respectively, when either
none or at least one clinical sign or lesion compatible
with CanL was noted. Blood samples were collected
from the cephalic vein, and spotted into the middle of
a filter paper allowed to air-dry and stored at −20°C
until testing with the direct agglutination test (DAT)
for titration of anti-Leishmania antibodies [18,19].
The samples analysed in 1990 and 1999 were tested
by using a liquid DAT antigen prepared from Leish-
mania donovani promastigotes (strain 1-S) with a cut
off titre of 1:320 [16]. The samples collected in 2010
were analysed with DAT based on freeze dried anti-
gen, with a cut off titre of 1:400 [18,19]. Chi-square
test compared proportions of positivity (no. of dogs
found seropositive divided by the no. of dogs tested)
related to the categorical dependent variables location,Table 1 Percentages of seropositive dogs found in urban or r
Study
area
Year 1990 Year 1999
% seropositive
(No. dogs tested)
95% CI (%) % seropositiv
(No. dogs tes
Urban 4.9a (1,524) 3.9–6.1 ↑ 10.1 (1,661)
Rural 3.2a (2,090) 2.5–4.0 ↑ 8.8 (1,902)
Total 3.9 (3,614) 3.3–4.6 ↑ 9.4 (3,563)
a, b: statistically significant difference between areas; ↑↓: statistically significant diffegender and ability. The exact binomial test was used
to calculate confidence intervals (CI) for proportions,
with a 95% confidence level. Differences between the
ages of dogs were compared with the Mann–Whitney
U test. Analyses were done with StatLib or SPSS 11.5
software for Windows. A probability (p) value < 0.05
was regarded as statistically significant [20].
The serology data obtained in 1990 have been previously
reported [16], but again presented in the current paper to
allow a comparison over a time period of 20 years. The
total numbers of DAT seropositive dogs were 141 (3.9%) in
1990, 335 (9.4%) in 1999 and 84 (5.6%) in 2010. The overall
seroprevalence was significantly higher in 1999 (9.4%)
compared to 1990 (3.9%), but in 2010 a significant decrease
in seroprevalence (5.6%) was found compared to 1999
(Table 1). Nevertheless, the overall seroprevalence was sig-
nificantly higher in 2010 compared to 1990. From 1990 to
1999 the total increase in seroprevalence was simultaneous
with significant increases in both the urban and rural areas.
On the other hand, from 1999 to 2010 the decrease in
seroprevalence was simultaneous with a significant de-
crease only in the urban area (Table 1). At last, when
comparing the years 1990 and 2010, the increase in sero-
prevalence was simultaneous with a significant increase
only in the rural area. A questionnaire conducted in
Portugal in the year 2006 revealed that dog owners in
urban areas had a significantly higher knowledge on
CanL compared to the rural ones [21]. No data is avail-
able on the prophylactic measures applied to dogs from
Évora, but it might be possible that preventatives [22], es-
pecially insecticides with a repellent effect, have increas-
ingly been used on dogs from the urban area.
Out of the 141 seropositive dogs in 1990, 113 (80.1%)
were apparently healthy and 28 (19.9%) were considered
clinically suspect (0.8% of the total study population in
1990). Similar observations were made in 1999 and
2010, when 263 healthy dogs (78.5%) and 72 (21.5%)
suspect dogs (2.0% of the total study population) were
DAT positive (out of the total of 335 animals) and 71
(80.1%) healthy and 13 (9.9%) suspect dogs (0.9% of the
total study population) were seropositive (out of 84), re-
spectively. From 1990 to 1999 there was a significant in-
crease in the percentages of suspect dogs among the




95% CI (%) % seropositive
(No. dogs tested)
95% CI (%)
8.7-11.7 ↓ 3.3b (675) 2.1–4.9
7.5-10.1 7.6b (820) 5.8–9.6
8.5-10.4 ↓ 5.6 (1,495) 4.5–6.9
rence to the previous year, for the same area.
Table 2 Percentages of seropositive dogs in relation to
gender and ability








Female 3.4 (1,926) ↑ 9.3 (1,837) ↓ 6.2 (796)
Male 4.5 (1,688) ↑ 9.5 (1,726) ↓ 5.0 (699)
Ability
Guard 3.6 (1,483) ↑ 7.9* (1,702) ↓ 3.7* (854)
Hunting 3.8 (992) ↑ 13.7* (774) 11.0* (227)
Pet 4.7 (656) 5.9* (612) 3.7 (246)
Shepherd 3.4 (351) ↑ 12.1 (298) ↓ 5.0 (119)
Stray 11.5 (61) 17.9* (117) ↑ 41.4* (29)
ND 0.0 (71) 3.3 (60) 0.0 (20)
Total 3.9 (3,614) ↑ 9.4 (3,563) ↓ 5.6 (1,495)
↑↓: statistically significant difference to the previous year; *: statistically
significant difference to the total, for the same year; ND: no data on
ability available.
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proportions of clinically suspect dogs among the sero-
positive ones were not statistically significant when
comparing the years 1990–1999 or 1999–2010. The
percentage of clinically suspect dogs among the total
populations seems to have followed that of the sero-
positivity. Among every 5.0 (year 1990), 4.7 (year 1999)
or 6.5 (year 2010) seropositive dogs there was one ani-
mal clinically suspect of CanL. Lymphadenopathy (69.2-
89.3%), followed by onychogryphosis (53.2-59.7%) and
skin involvement (38.9-46.4%), were the most frequently
observed clinical manifestations in the present study
and are among those most commonly found [3,4]. The
number of dogs with overt disease is thus relatively
low, but at a comparable level found in other studies in
the Iberian Peninsula [4,14].
Gender associated differences between male and fe-
male seroprevalences were not found in this study
(Table 2) and are in line with previous observations
[4,14,23], but in contrast to some other studies in
which a higher prevalence was observed in males [24].
With respect to ability or occupation of the dogs, it
was noted that the highest levels of seropositivity wereTable 3 Relationship between age of dogs and seropositivity
DAT Year 1990 Year
Mean age (± SD) – years No. dogs Mean age (±
Seropositive 7.04 (± 2.71)a 141 6.96 (±
Seronegative 4.71 (± 2.40)a 3,473 ↑5.26 (±
Total 4.80 (± 2.46) 3,614 ↑5.42 (
DAT: direct agglutination test; SD: standard deviation; a, b, c: statistical significant di
difference to the previous year; *: age was not determined for one dog.found among stray dogs, but the majority of seroposi-
tive dogs in absolute numbers were mainly working ani-
mals, including guard and hunting dogs (Table 2). An
association between age and seroprevalence was also
observed (Table 3), in all three rounds of sample collec-
tion, and confirmed previous findings that dogs of older
age are at a higher risk of being seropositive [4,8,15].
The findings of the presented surveys reveal that a
considerable number of dogs from Évora are seropositive
for CanL. A peak in seropositivity was observed in 1999
and there is a decline in the number of positive cases in
2010. It should however be noted that the total number
of dogs sampled in 2010 was much lower (< 50%) com-
pared to previous sample rounds. This could be due to
the fact that people, perhaps influenced by the current
economic crisis, are becoming reluctant to have their
dogs anti-rabies-vaccinated and tested, and may dispose
of animals with ill health (in 2010 only 13 animals with
clinical signs of CanL were found in the present study).
This may bias, i.e. underestimate, the true seropreva-
lence in the region. The reported seroprevalences are in
a comparable range to those reported in other studies
from Portugal [25,26]. Also, in other countries in the
Mediterranean basin a rather wide range of seropreva-
lence is being reported [4,6,8].Conclusions
In conclusion, there is a high proportion of dogs that are
seropositive for CanL in the municipality of Évora in
Portugal but that appear as clinically healthy. If in ana-
logy to human infections [27] where asymptomatic cases
are thought to be also in the majority, with an estimated
ratio of > 100 asymptomatic individuals per each clinical
case, the number of infected dogs could be enormous.
Indeed, it is difficult to provide an actual number of
infected dogs, but it has been estimated based on sero-
prevalence studies that 2.5 million dogs from Italy,
France, Spain and Portugal are infected [2]. It remains a
concern that so many animals are possibly infected with
L. infantum and that they may transmit the parasite
either to other dogs or humans [3,28]. Therefore, control
efforts should remain focussed on canines, but also the
human population in these regions should be better
monitored too.1999 Year 2010
SD) – years No. dogs Mean age (± SD) – years No. dogs
2.98)b 335 6.57 (± 3.37)c 84
2.76)b 3,227 5.34 (± 2.81)c 1,411
± 2.82) 3,562* 5.41 (± 2.86) 1,495
fference between seropositive and seronegative; ↑: statistical significant
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